About Us
About Us
Group Overview
Management Team
History of Chipscreen Bioscences
Intellectual Property
Honors
Social Responsibility
Our Partners
Research & Development
Research & Development
Core Technologies
Therapeutic Areas
Research & Development System
Product Lifecycle Management
Pipeline
Pipeline
Pipelines
Chidamide
Chiglitazar
Chiauranib
CS12192
News & Reports
News & Reports
Company News
Media Reports
Notice & Announcement
Video Library
Contact Us
Contact Us
Contact Details
Investor Relations
Patient Care
Working at Chipscreen
CN
EN
Investors
Investors
Company Announcements
Periodic Reports
Patient Care
Patient Care
Safety
Chidamide Donation
Adverse Event/Reaction Reports
Career
Career
Career Development
Career Opportunities
Emplyee Benefits
Employee Growth
Our Staff
CN
Search...
Home
News & Reports
How difficult is drug innovation? This company from the STAR Market claims: We p...
How difficult is drug innovation? This company from the STAR Market claims: We plan to spend 1 billion Yuan over 10 years to select one from 10,000 compounds | Cloud Research (http://www.p5w.net/)
August 13,2019
Back to List
More Press Releases
2019.04.28
《Nature 》Spotlight on Shenzhen：A pioneer in drug innovation
《Nature 》Spotlight on Shenzhen：A pioneer in drug innovation
Full text
2020.06.30
Master Class of SSE about Science & Technology Innovation: Development and Opportunities of Chinese Innovative Drugs
Master Class of SSE about Science & Technology Innovation: Development and Opportunities of Chinese Innovative Drugs
Full text
2020.07.27
A breast cancer study on a Chinese brand-name drug has been published on Lancet
A breast cancer study on a Chinese brand-name drug has been published on Lancet
Full text
